• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of bmjLink to Publisher's site
BMJ. Apr 4, 1992; 304(6831): 883–887.
PMCID: PMC1882822

Edinburgh primary care depression study: treatment outcome, patient satisfaction, and cost after 16 weeks.


OBJECTIVE--To compare the clinical efficacy, patient satisfaction, and cost of three specialist treatments for depressive illness with routine care by general practitioners in primary care. DESIGN--Prospective, randomised allocation to amitriptyline prescribed by a psychiatrist, cognitive behaviour therapy from a clinical psychologist, counselling and case work by a social worker, or routine care by a general practitioner. SUBJECTS AND SETTING--121 patients aged between 18 and 65 years suffering depressive illness (without psychotic features) meeting the criteria of the Diagnostic and Statistical Manual of Mental Disorders, Third Edition for major depressive episode in 14 primary care practices in southern Edinburgh. MAIN OUTCOME MEASURES--Standard observer rating of depression at outset and after four and 16 weeks. Numbers of patients recovered at four and 16 weeks. Total length and cost of therapist contact. Structured evaluation of treatment by patients at 16 weeks. RESULTS--Marked improvement in depressive symptoms occurred in all treatment groups over 16 weeks. Any clinical advantages of specialist treatments over routine general practitioner care were small, but specialist treatment involved at least four times as much therapist contact and cost at least twice as much as routine general practitioner care. Psychological treatments, especially social work counselling, were most positively evaluated by patients. CONCLUSIONS--The additional costs associated with specialist treatments of new episodes of mild to moderate depressive illness presenting in primary care were not commensurate with their clinical superiority over routine general practitioner care. A proper cost-benefit analysis requires information about the ability of specialist treatment to prevent future episodes of depression.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Goldberg DP, Blackwell B. Psychiatric illness in general practice. A detailed study using a new method of case identification. Br Med J. 1970 May 23;1(5707):439–443. [PMC free article] [PubMed]
  • Watson JM, Barber JH. Depressive illness in general practice: a pilot study. Health Bull (Edinb) 1981 Mar;39(2):112–116. [PubMed]
  • Porter AM. Depressive illness in a general practice. A demographic study and a controlled trial of imipramine. Br Med J. 1970 Mar 28;1(5699):773–778. [PMC free article] [PubMed]
  • Blashki TG, Mowbray R, Davies B. Controlled trial of amitriptyline in general practice. Br Med J. 1971 Jan 16;1(5741):133–138. [PMC free article] [PubMed]
  • Thomson J, Rankin H, Ashcroft GW, Yates CM, McQueen JK, Cummings SW. The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo. Psychol Med. 1982 Nov;12(4):741–751. [PubMed]
  • Paykel ES, Hollyman JA, Freeling P, Sedgwick P. Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial. J Affect Disord. 1988 Jan-Feb;14(1):83–95. [PubMed]
  • Johnson DA. Treatment of depression in general practice. Br Med J. 1973 Apr 7;2(5857):18–20. [PMC free article] [PubMed]
  • Trethowan WH. Pills for personal problems. Br Med J. 1975 Sep 27;3(5986):749–751. [PMC free article] [PubMed]
  • Lader M. Advances in drugs - boon or curse? The social implications of psychotropic drugs. R Soc Health J. 1975 Dec;95(6):304–305. [PubMed]
  • Tyrer P. Drug treatment of psychiatric patients in general practice. Br Med J. 1978 Oct 7;2(6143):1008–1010. [PMC free article] [PubMed]
  • Cooper B, Sylph J. Life events and the onset of neurotic illness: an investigation in general practice. Psychol Med. 1973 Nov;3(4):421–435. [PubMed]
  • Sireling LI, Freeling P, Paykel ES, Rao BM. Depression in general practice: clinical features and comparison with out-patients. Br J Psychiatry. 1985 Aug;147:119–126. [PubMed]
  • Blackburn IM, Bishop S, Glen AI, Whalley LJ, Christie JE. The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry. 1981 Sep;139:181–189. [PubMed]
  • Teasdale JD, Fennell MJ, Hibbert GA, Amies PL. Cognitive therapy for major depressive disorder in primary care. Br J Psychiatry. 1984 Apr;144:400–406. [PubMed]
  • HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56–62. [PMC free article] [PubMed]
  • Elkin I, Shea MT, Watkins JT, Imber SD, Sotsky SM, Collins JF, Glass DR, Pilkonis PA, Leber WR, Docherty JP, et al. National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch Gen Psychiatry. 1989 Nov;46(11):971–983. [PubMed]
  • Ormel J, Van Den Brink W, Koeter MW, Giel R, Van Der Meer K, Van De Willige G, Wilmink FW. Recognition, management and outcome of psychological disorders in primary care: a naturalistic follow-up study. Psychol Med. 1990 Nov;20(4):909–923. [PubMed]
  • Glen AI, Johnson AL, Shepherd M. Continuation therapy with lithium and amitriptyline in unipolar depressive illness: a randomized, double-blind, controlled trial. Psychol Med. 1984 Feb;14(1):37–50. [PubMed]
  • Simons AD, Murphy GE, Levine JL, Wetzel RD. Cognitive therapy and pharmacotherapy for depression. Sustained improvement over one year. Arch Gen Psychiatry. 1986 Jan;43(1):43–48. [PubMed]
  • Blackburn IM, Eunson KM, Bishop S. A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. J Affect Disord. 1986 Jan-Feb;10(1):67–75. [PubMed]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Group


Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...


  • Cited in Books
    Cited in Books
    PubMed Central articles cited in books
  • Compound
    PubChem Compound links
  • MedGen
    Related information in MedGen
  • PubMed
    PubMed citations for these articles
  • Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...